Coly-mycin Injection
Product Images NDC 42023-107

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Coly-mycin (NDC 42023-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Coly Mycin M 1)

Chemical structure diagram of colistimethate's active ingredient, illustrating the molecular groups including 2,4-diaminobutanoic acid (Dbu) and methylpentyl groups (R) as present in colistin A and colistin B.*

FDA Label Image

Figure (Coly Mycin M 2)

A line graph showing colistin base activity levels measured in urine and serum over a 12-hour period following intramuscular (IM) or intravenous (IV) administration of Coly-Mycin M injection. Four lines represent urine levels for IV and IM and serum levels for IV and IM routes, illustrating the decline in activity concentration over time.*

FDA Label Image

Coly Mycin M Parenteral Carton (Coly Mycin M 3)

Packaging label for Coly-Mycin M Parenteral (colistimethate for injection, USP) 150 mg/vial by Par Pharmaceutical. The label states it is for intramuscular and intravenous use, with colistin base activity. It includes dosage storage instructions and cautions, and shows the NDC 42023-107-01 with a single dose vial packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.